All Articles

Rentokil Terminix is betting on data, not just chemicals, to win the pest control war. How smart sensors and Google bookings are changing an age-old industry.

As of July 14, the CRA is moving all business registrations online. This promises instant access for many but creates new hurdles for some entrepreneurs.

The opening of the 134-unit Habiter chez soi project in Gatineau showcases a powerful, multi-layered partnership model for tackling Canada's housing crisis.

With inflation outpacing typical returns, new data reveals a fractured savings landscape. For today's saver, the greatest risk is not volatility, but inertia.

A novel drug aims to reverse myelin damage in MS, a feat no current therapy can achieve. But with a recent FDA hold, is Quantum BioPharma's vision a breakthrough or a mirage?

With traditional banks reducing SME lending, White Oak UK is injecting £1.5B into key industrial sectors, signaling a major shift in business finance.

For 10 years, Charles Schwab has been one of America's most community-minded firms. We dissect how its integrated model is more than charity—it's a strategy.

Quoin Pharma's new drug name is a key step, but the path to the first-ever treatment for a rare skin disease reveals the complex interplay of innovation and finance.

A new partnership puts high-purity recycled plastic in food containers, a breakthrough that helps brands meet tough new laws and growing consumer demand.

NewtekOne just automated a tedious part of getting a business loan. But the real story is its plan to sell this tech to other banks, changing its own game.

Former AF Group CEO Elizabeth Haar joins Prescient National's board, signaling a major strategic push to reshape its national footprint and innovate.

Hamilton just opened a $390M transit facility. It's not just a garage; it's the critical nerve center for the city's ambitious future of growth and mobility.

A new report reveals a fractured U.S. housing landscape. While most of the nation sees buyer power grow, tech booms are fueling fierce bidding wars in others.

A Canadian biotech is developing a novel cancer drug. We look beyond the paid promotions to analyze the science, the strategy, and the high-stakes reality.

As quantum threats loom, SEALSQ is set to unveil its U.S. roadmap for hardware-based security, a critical move for national defense and supply chains.

As autonomous AI agents multiply, creating chaos and risk, a new class of governance is emerging. A key partnership shows how enterprises can regain control.

With 4K laser projectors at 50% off, Dangbei is betting big that consumers will ditch the TV for a massive, cinematic experience that disappears on command.

With a new AI research lab and a $52M Series A, Niural is tackling the hardest problem in AI: building agents for domains where the margin for error is zero.

A new US policy designates cartels as terrorists, turning Latin American banks into a compliance minefield. The stakes are existential, and the financial network is the front line.